Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Dow
Boehringer Ingelheim
Julphar
Fish and Richardson
Novartis
Farmers Insurance
Moodys
Healthtrust
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,027,859

« Back to Dashboard

Summary for Patent: 7,027,859
Title:Electrotransport delivery device having improved safety and reduced abuse potential
Abstract:An electrotransport device (20) for delivering one or more therapeutic agents through the skin includes electrodes (30,32) for contacting the skin (34), at least one electrode containing the agent, a power source (22) for generating electrical current (I.sub.L) for delivering the agent, a current generating and controlling means (24), and a disabling means (26) for permanently and irreversibly disabling the current. The disabling means (26) may include a timer means (66), a counter means (82), or a body parameter sensor (134) and limit comparator (132) to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source (22), or a permanent diversion of electrotransport current from the electrodes (30,32), or a combination of the above. The permanent disabling means may include a circuit connection means (304,308,326,328) having a frangible conducting member (332) which permanently fractures and causes an irreversible open circuit in the connection to the electrodes (334,342) upon removing a disposable/single use electrode assembly (300) from a reusable portion of an electrotransport device.
Inventor(s): McNichols; Larry A. (Coon Rapids, MN), Badzinski; John D. (Coon Rapids, MN), Reining; William N. (Cross Plains, WI), Lattin; Gary A. (Forest Lake, MN), Haak; Ronald P (Menlo Park, CA), Phipps; Joseph B. (Plymouth, MN)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:08/312,336
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Drugs Protected by US Patent 7,027,859

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,027,859

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 173942 ➤ Subscribe
Australia 3594095 ➤ Subscribe
Canada 2195657 ➤ Subscribe
Germany 69506426 ➤ Subscribe
Denmark 0781152 ➤ Subscribe
European Patent Office 0781152 ➤ Subscribe
Spain 2125660 ➤ Subscribe
Japan 2008220985 ➤ Subscribe
Japan 4165659 ➤ Subscribe
Japan 4322304 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
McKesson
Julphar
Medtronic
Baxter
Moodys
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot